A Kaplan–Meier analysis regarding death or lung transplantation demonstrated that the event-free rate was significantly lower in PAH patients with the RNF213 p.Arg4810Lys variant than in those with BMPR2 mutations [9]. The gene discussed is RNF213; the disease is pulmonary arterial hypertension.